Abstract
Schizophrenia and bipolar disorder are associated with different clinical profiles of disturbances in motivation, yet few studies have compared the neurophysiological correlates of such disturbances. Outpatients with schizophrenia (n = 34), or bipolar disorder I (n = 33), and healthy controls (n = 31) completed a task in which the late positive potential (LPP), an index of motivated attention, was assessed along motivational gradients determined by apparent distance from potential rewards or punishments. Sequences of cues signaling possible monetary gains or losses appeared to loom progressively closer to the viewer; a reaction time (RT) task after the final cue determined the outcome. Controls showed the expected pattern with LPPs for appetitive and aversive cues that were initially elevated, smaller during intermediate positions, and escalated just prior to the RT task. The clinical groups showed different patterns in the final positions just prior to the RT task: the bipolar group's LPPs to both types of cues peaked relatively early during looming sequences and subsequently decreased, whereas the schizophrenia group showed relatively small LPP escalations, particularly for aversive cues. These distinct patterns suggest that the temporal unfolding of attentional resource allocation for motivationally significant events may qualitatively differ between these disorders.
Original language | English |
---|---|
Pages (from-to) | 576-587 |
Number of pages | 12 |
Journal | Journal of Abnormal Psychology |
Volume | 125 |
Issue number | 4 |
DOIs | |
State | Published - 1 May 2016 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2016 American Psychological Association.
Funding
Support for this study came from a National Institute of Mental Health Grants MH091468 (William P. Horan) and MH065707 and MH43292 (Michael F. Green). We thank Amanda Bender, Michelle Dolinsky, Crystal Gibson, Cory Tripp, and Katherine Weiner for assistance in data collection. Michael F. Green has been a consultant to AbbVie, DSP, Forum, and Takeda, and he is on the scientific advisory board of Mnemosyne. He has received research funds from Amgen and Forum. The rest of the authors report no biomedical financial interests or potential conflicts of interest.
Funders | Funder number |
---|---|
National Institutes of Health | |
National Institute of Mental Health | MH43292, R01MH065707, R21MH091468 |
Takeda Pharmaceutical Company |
Keywords
- Bipolar disorder
- Event-related potentials
- Motivation
- Psychological distance
- Schizophrenia